Ajanta Pharma Limited (AJANTPHARM): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Ajanta Pharma Limited, explained in plain English.

• ▪Ajanta Pharma Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪AJANTPHARM closed at ₹3,508.80 on 30 October 2026.
• ▪Over the past year the shares are up 42.1%, trading between ₹2,430.00 and ₹3,796.00.
• ▪Reported fundamentals show a net margin of 19.65%, debt to equity of 5.87.
• ▪Our transparent MaxGrade checklist scores it A (81/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 25.97% with a maximum drawdown of -13.16% and a beta of 0.53 against NIFTY 50.

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma, Biocon

Last traded values from 30 Oct 2026. Market closed.